Literature DB >> 33161121

Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease.

Takumi Yasuno1, Tomoyuki Ohe2, Hiroki Kataoka1, Kosho Hashimoto1, Yumiko Ishikawa1, Keigo Furukawa1, Yasuhiro Tateishi1, Toi Kobayashi1, Kyoko Takahashi1, Shigeo Nakamura3, Tadahiko Mashino4.   

Abstract

In the present study, we newly synthesized three types of novel fullerene derivatives: pyridinium-type derivatives trans-3a and 4a-5b, piperidinium-type derivative 9, and proline-type derivatives 10a-12. Among the assessed compounds, 5a, 10e, 10f, 10i, 11a-d, and 12 were found to inhibit both HIV reverse transcriptase and HIV protease (HIV-PR), with IC50 values in the low micromolar range being observed. Regarding HIV-PR inhibition activity, proline-type derivatives 11a-11d and 12, bearing an alkyl chain between the hydroxylmethylcarbonyl (HMC) moiety and pyrrolidine ring, were more potent than other derivatives. This result might indicate that connecting HMC moieties with proline-type fullerene derivatives through properly sized alkyl chain leads to improved HIV-PR inhibitory activity.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fullerene; HIV protease; HIV reverse transcriptase

Mesh:

Substances:

Year:  2020        PMID: 33161121     DOI: 10.1016/j.bmcl.2020.127675

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin.

Authors:  Ayano Kadota; Misato Moriguchi; Tadashi Watanabe; Yuichi Sekine; Shigeo Nakamura; Takumi Yasuno; Tomoyuki Ohe; Tadahiko Mashino; Masahiro Fujimuro
Journal:  Oncol Rep       Date:  2022-01-11       Impact factor: 3.906

2.  Fullerene Derivatives Prevent Packaging of Viral Genomic RNA into HIV-1 Particles by Binding Nucleocapsid Protein.

Authors:  Ivana Křížová; Alžběta Dostálková; Edison Castro; Jan Prchal; Romana Hadravová; Filip Kaufman; Richard Hrabal; Tomáš Ruml; Manuel Llano; Luis Echegoyen; Michaela Rumlová
Journal:  Viruses       Date:  2021-12-06       Impact factor: 5.048

3.  Toxic Effect of Fullerene and Its Derivatives upon the Transmembrane β2-Adrenergic Receptors.

Authors:  Longlong Ren; Zhenxiang Jing; Fei Xia; John Zenghui Zhang; Yang Li
Journal:  Molecules       Date:  2022-07-18       Impact factor: 4.927

4.  Fullerenes against COVID-19: Repurposing C60 and C70 to Clog the Active Site of SARS-CoV-2 Protease.

Authors:  Tainah Dorina Marforio; Edoardo Jun Mattioli; Francesco Zerbetto; Matteo Calvaresi
Journal:  Molecules       Date:  2022-03-16       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.